Free Trial

Agios Pharmaceuticals (AGIO) News Today

Agios Pharmaceuticals logo
$29.80 +0.21 (+0.71%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$29.79 -0.01 (-0.03%)
As of 05/23/2025 05:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AGIO Latest News

Agios Pharmaceuticals, Inc. stock logo
Bank of America Corp DE Raises Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Bank of America Corp DE lifted its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 21.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 404,902 shares of the biopharmaceutical co
Agios Pharmaceuticals, Inc. stock logo
Frazier Life Sciences Management L.P. Has $35.15 Million Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Frazier Life Sciences Management L.P. lifted its stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 2.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,069,754 shar
Agios Pharmaceuticals, Inc. stock logo
Twinbeech Capital LP Purchases Shares of 141,073 Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Twinbeech Capital LP purchased a new stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 141,073 shares of the biophar
Agios Pharmaceuticals, Inc. stock logo
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares Sold by Rafferty Asset Management LLC
Rafferty Asset Management LLC cut its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 21.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 70,313 shares of the biopharmaceutical
Agios Pharmaceuticals, Inc. stock logo
Tema Etfs LLC Makes New Investment in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Tema Etfs LLC bought a new stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 25,735 shares of the biopharmaceutical company's stock, valued at approximately $846,000. A
Agios Pharmaceuticals, Inc. stock logo
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares Sold by Polar Capital Holdings Plc
Polar Capital Holdings Plc decreased its stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 37.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 627,036 shares of the biopharmaceutical com
Agios Pharmaceuticals, Inc. stock logo
Paradigm Biocapital Advisors LP Makes New $9.08 Million Investment in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Paradigm Biocapital Advisors LP bought a new stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 276,439 shares of the biopharmaceutical comp
Agios Pharmaceuticals, Inc. stock logo
Patient Square Capital LP Invests $4 Million in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Patient Square Capital LP purchased a new position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 121,732 shares of the biopharmaceutical company'
Agios Pharmaceuticals, Inc. stock logo
Deutsche Bank AG Boosts Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Deutsche Bank AG grew its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 39.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 935,252 shares of the biopharmaceutical company's stock a
Agios Pharmaceuticals, Inc. stock logo
Orbimed Advisors LLC Invests $877,000 in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Orbimed Advisors LLC purchased a new stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 26,700 shares of the biopharmaceutical compa
Agios Pharmaceuticals, Inc. stock logo
Moore Capital Management LP Sells 40,000 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Moore Capital Management LP lowered its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 40.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 60,000 shares of the biopharmaceutical company'
Agios Pharmaceuticals, Inc. stock logo
Hudson Bay Capital Management LP Boosts Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Hudson Bay Capital Management LP boosted its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 83.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 110,000 shares of the bi
Agios Pharmaceuticals, Inc. stock logo
D. E. Shaw & Co. Inc. Sells 15,929 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
D. E. Shaw & Co. Inc. lowered its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 3.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 516,475 shares of the biopharmaceutic
Agios Pharmaceuticals, Inc. stock logo
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Stake Lessened by Algert Global LLC
Algert Global LLC lowered its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 67.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,240 shares of the biopharmaceutical comp
Agios Pharmaceuticals, Inc. stock logo
Jefferies Financial Group Inc. Invests $49.29 Million in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Jefferies Financial Group Inc. acquired a new stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,500,000 shares of the biopharmaceutical company's stock, valued
Agios Pharmaceuticals, Inc. stock logo
Granahan Investment Management LLC Sells 35,098 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Granahan Investment Management LLC lessened its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 23.3% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 115,687 shares of the biopharmaceutical company's stock
Agios Pharmaceuticals, Inc. stock logo
Crestline Management LP Acquires New Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Crestline Management LP bought a new position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 18,105 shares of the biopharmaceutical compan
Agios Pharmaceuticals, Inc. stock logo
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) has been given a consensus rating of "Moderate Buy" by the nine brokerages that are currently covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating and five have issued a buy rating
Agios Pharmaceuticals, Inc. stock logo
Balyasny Asset Management L.P. Makes New Investment in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Balyasny Asset Management L.P. acquired a new stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 248,038 shares of the biopharmaceutical company's stock, valued at app
Agios Pharmaceuticals, Inc. stock logo
Agios Pharmaceuticals (NASDAQ:AGIO) Stock Rating Upgraded by StockNews.com
StockNews.com raised Agios Pharmaceuticals from a "sell" rating to a "hold" rating in a research note on Saturday.
Agios Pharmaceuticals, Inc. stock logo
Farallon Capital Management LLC Boosts Stock Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Farallon Capital Management LLC grew its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 0.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,674,466 shares of the biopharmaceutical company's stock
Agios Pharmaceuticals, Inc. stock logo
Jane Street Group LLC Grows Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Jane Street Group LLC lifted its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 58.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 214,027 shares of the biop
Agios Pharmaceuticals, Inc. stock logo
The Manufacturers Life Insurance Company Reduces Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
The Manufacturers Life Insurance Company reduced its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 14.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 122,094 shares of the biophar
Agios Pharmaceuticals, Inc. stock logo
Rep. Gilbert Ray Cisneros, Jr. Buys Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Stock
Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO). In a filing disclosed on May 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Agios Pharmaceuticals stock on April 17th. The trade occurr
Agios Pharmaceuticals, Inc. stock logo
Brevan Howard Capital Management LP Has $1.56 Million Stock Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Brevan Howard Capital Management LP boosted its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 341.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 47,326 shares of the biopharmaceutical
Agios Pharmaceuticals, Inc. stock logo
Axa S.A. Sells 63,373 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Axa S.A. lowered its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 26.5% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 175,377 shares of the biopharmaceutical company's stock after selling 63,373 shares during the period.
Agios Pharmaceuticals, Inc. stock logo
Tudor Investment Corp ET AL Makes New $938,000 Investment in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Tudor Investment Corp ET AL purchased a new stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 28,553 shares of the
Agios Pharmaceuticals, Inc. stock logo
Voya Investment Management LLC Lowers Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Voya Investment Management LLC reduced its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 48.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,007 shares of the biopha
Agios Pharmaceuticals, Inc. stock logo
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares Purchased by Cutter Capital Management LP
Cutter Capital Management LP lifted its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 61.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 301,623 sh
Agios Pharmaceuticals, Inc. stock logo
Casdin Capital LLC Takes $8.22 Million Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Casdin Capital LLC acquired a new position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 250,000 shares of the biopharmaceutical company's stock, valued at approximately $8,215
Agios Pharmaceuticals, Inc. stock logo
BVF Inc. IL Sells 116,352 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
BVF Inc. IL decreased its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 9.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,073,755 shares of the biopharmaceutica
Agios Pharmaceuticals, Inc. stock logo
Bellevue Group AG Trims Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Bellevue Group AG lowered its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 5.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,515,150 shares of the biopharmaceutical company's stock after s
Agios Pharmaceuticals, Inc. stock logo
Hsbc Holdings PLC Acquires 25,752 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Hsbc Holdings PLC increased its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 532.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,584 shares of the b
Agios Pharmaceuticals, Inc. stock logo
Dimensional Fund Advisors LP Sells 233,118 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Dimensional Fund Advisors LP cut its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 14.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,329,065 shares of the biopharmaceutical company's stoc
Agios Pharmaceuticals, Inc. stock logo
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares Sold by First Trust Advisors LP
First Trust Advisors LP reduced its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 12.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 97,259 shares of the biopharmaceutical company's stock after selling 13,664 shares
Agios Pharmaceuticals, Inc. stock logo
Agios Pharmaceuticals (NASDAQ:AGIO) Announces Earnings Results
Agios Pharmaceuticals (NASDAQ:AGIO - Get Free Report) posted its earnings results on Thursday. The biopharmaceutical company reported ($1.55) earnings per share for the quarter, topping the consensus estimate of ($1.80) by $0.25. Agios Pharmaceuticals had a net margin of 1,845.92% and a negative return on equity of 2.51%.
Agios Pharmaceuticals, Inc. stock logo
ArrowMark Colorado Holdings LLC Acquires 34,689 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
ArrowMark Colorado Holdings LLC boosted its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 3.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 917,420 shares of the biophar
Agios Pharmaceuticals, Inc. stock logo
PDT Partners LLC Reduces Stock Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
PDT Partners LLC lessened its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 85.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 8,485 shares of the biopharmaceutical company's stock after selling 48
Agios Pharmaceuticals, Inc. stock logo
Scotiabank Cuts Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $71.00
Scotiabank cut their price objective on shares of Agios Pharmaceuticals from $74.00 to $71.00 and set a "sector outperform" rating for the company in a report on Friday.
Agios Pharmaceuticals, Inc. stock logo
Leerink Partnrs Brokers Decrease Earnings Estimates for AGIO
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Equities research analysts at Leerink Partnrs dropped their Q2 2025 earnings per share estimates for Agios Pharmaceuticals in a research report issued on Monday, April 28th. Leerink Partnrs analyst A. Berens now anticipates that the biopha
Agios Pharmaceuticals, Inc. stock logo
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is Caligan Partners LP's 7th Largest Position
Caligan Partners LP increased its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 8.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 626,280 shares of the biopharmaceu
Get Agios Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter.

AGIO Media Mentions By Week

AGIO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AGIO
News Sentiment

1.23

0.75

Average
Medical
News Sentiment

AGIO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AGIO Articles
This Week

7

6

AGIO Articles
Average Week

Get Agios Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:AGIO) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners